Recently published American College of Cardiology (ACC)/American Heart Association (AHA) guidelines state that patients with suspected coronary disease and an intermediate pretest probability are appropriate candidates for exercise ECG, while those with low or high pretest probability are not. Methods: From 5,103 consecutive patients with symptoms of suspected coronary disease, we evaluated 872 patients who underwent coronary angiography following exercise ECG. Differences in test performance were determined using receiver operating characteristic curve area analysis. A score using age, gender, symptoms, and risk factors was used to classify patients into low, intermediate, and high pretest probability groups. Results: When patients with inadequate exercise tests were excluded, overall sensitivity and specificity were 70% and 66%, respectively. Only the intermediate pretest probability group demonstrated significant incremental value: pretest vs posttest intermediate, 70 ؎ 3 vs 79 ؎ 3 (p < 0.0001); low, 71 ؎ 6 vs 76 ؎ 7 (p ‫؍‬ 0.39); and high, 69 ؎ 8 vs 75 ؎ 7 (p ‫؍‬ 0.12). From the low-to the high-probability groups, there was a progressive increase in positive predictive value (21%, 62%, and 92%) and decrease in negative predictive value (94%, 72%, and 28%), respectively. The frequencies of abnormal exercise ECGs were lower in the unselected groups compared with the angiography groups (low, 13% vs 36%; intermediate, 22% vs 53%; high, 36% vs 63%). Conclusions: Based on the information added by exercise testing to clinical data, these results confirm the ACC/AHA guideline assignments for test selection. However, despite these guidelines, patients with a low pretest probability can be selected for exercise testing with the knowledge that a positive result is infrequent and a negative result carries a very high negative predictive value. Intermediateprobability patients on average carry a significant false-negative rate, suggesting that exercise ECG alone may not be a sufficient screening test in all intermediate-probability patients. Because of poor negative predictive value and a large percentage of negative tests, high-probability patients should undergo coronary angiography as the initial strategy, unless the goal of exercise testing is to assess prognosis.
R
ecently, a joint consensus of the American College of Cardiology (ACC) and the American Heart Association (AHA) published guidelines for the indications for exercise ECG in patients with symptoms of suspected coronary disease. 1 In that document, a class I indication, appropriate usage, was given to patients with an intermediate pretest probability of coronary disease. A class IIb indication, may be appropriate, was given to patients with either low or high pretest probabilities. These assignments were given because ". . . the test result has the largest potential effect on diagnostic outcome . . . " in the intermediate group. 1 Therefore, the purpose of the present study was to assess the accuracy and the value of the exercise ECG in groups of patients stratified by the pretest probability of coronary disease.
Materials and Methods

Patient Population
We screened all inpatients and outpatients referred by primary-care physicians and cardiologists to the stress laboratory for their first exercise test at West Virginia University Hospital between 1981 and 1998. First exercise tests included exercise ECG, nuclear, or echocardiographic studies. We included only symptomatic patients referred with the expressed purpose of evaluating the presence of coronary disease. We considered both the entire population of patients (unselected group) and the subset of this group who underwent coronary angiography within 4 months following the exercise ECG (angiography group). We excluded asymptomatic patients, those receiving digitalis preparations, those with a history of prior myocardial infarction or coronary angiography, and those with resting ECGs that were considered uninterpretable (left ventricular hypertrophy, left bundle branch block, Wolff-Parkinson-White syndrome, or other significant downward displacement of the ST segment). Considering that this study involved a review of data previously acquired for clinical indications, we did not obtain a review by the Human Subjects Committee. However, we handled data so as to ensure patient confidentiality.
Baseline Clinical Information
We collected the following data from patients during a preexercise ECG interview: age, gender, symptoms, medication usage at the time of the exercise ECG, and other coronary risk factors. Patients had height and weight recorded. We classified chest pain using the three categories of Diamond 2 : typical angina, atypical angina, and nonanginal chest pain. Risk factors included the following: current or prior cigarette smoking; history of hypertension (receiving antihypertensive therapy); history of insulin-or noninsulin-requiring diabetes; history of high cholesterol level or receiving cholesterol-lowering therapy, family history of premature (Ͻ 60 years of age) coronary disease (infarction, coronary bypass or angioplasty, sudden death) in first-degree relatives; and obesity, defined as a body mass index Ͼ 27 kg/m 2 . In women, we determined estrogen status using previously published criteria. 3, 4 In general, women were estrogen-status negative if they were postmenopausal and not receiving estrogen replacement therapy. Otherwise, they were considered as estrogen-status positive.
We determined pretest probability group with a scoring method previously developed and validated 5 in our laboratory. The method is a weighted summation of points from the following factors: age, gender, symptoms, estrogen status, diabetes, hypertension, hyperlipidemia, smoking, family history of coronary disease, and obesity. The following point ranges define the pretest probability groups: low, 0 to 8; intermediate, 9 to 15; and high, 16 to 24.
Exercise Tests
All patients exercised using either Bruce or Cornell treadmill protocols. We read all studies in a blinded fashion. Using the 12 standard leads, we measured peak exercise or 3-min recovery ST-segment changes (60 ms following the J point, compared to the baseline between two PR segments). We qualitatively categorized peak exercise ST-segment slope as upsloping, horizontal, or downsloping. Positive ST-segment criteria consisted of Ն 1-mm horizontal/downsloping ST-segment depression.
Coronary Angiography
Coronary angiograms were performed for routine clinical indications and were interpreted visually, blinded to the clinical and exercise ECG data. Coronary artery disease presence was defined as a Ն 50% luminal diameter narrowing.
Statistical Analysis
For the angiography group, we calculated sensitivity, specificity, and predictive values using standard formulas. We compared continuous data using either t testing or the Wilcoxon test, depending on the normality of the data. We compared proportions using Fisher's Exact Test. All p values Ͻ 0.05 were considered significant.
Incremental value was defined as the additional information contributed by the exercise test over the information available from pretest clinical data. Incremental value was evaluated using receiver operating characteristic (ROC) curve area analysis to compare probabilities of coronary disease. 6 Pretest and postexercise test probabilities were determined using previously published algorithms. 5, 7 The incremental value was the difference between the curve areas of the pretest clinical and pretest clinical plus exercise test data. 8 In addition, to evaluate the impact of a positive vs a negative exercise test, we compared the probability of coronary disease presence given a positive exercise test with the probability of coronary disease presence given a negative exercise test (derived, respectively, from angiography data as true-positives/all positives and false-negatives/all negatives). Table 1 lists the clinical and exercise ECG characteristics of the angiography and unselected groups. The angiography group is compared to the patients who did not undergo angiography. Angiography patients had 2.5 times the frequency of positive exercise ECGs, and had a lower proportion of low pretest probability patients.
Results
Patient Population
Exercise Test Accuracy
Overall, sensitivity and specificity in the 872 angiography patients were 42% (149 of 354) and 80% (413 of 518), respectively. Positive and negative predictive values were 59% and 67%, respectively. Table 2 displays the results for the subgroup of 518 angiography patients who achieved an adequate exercise study defined as either (1) a positive exercise test, or (2) a negative exercise test with an adequate exercise heart rate in the absence of certain medications. Adequate exercise heart rate achievement means that the peak exercise heart rate was Ն 85% of the maximum predicted heart rate (ie, 200 beats/ min minus age). No medications means that we excluded from the analysis patients who were receiving ␤-blockers, calcium channel blockers, or nitrates at the time of their exercise ECG. Compared to the entire angiographic group, there was a significant increase in sensitivity from 42 to 70% (p Ͻ 0.00001), and a significant fall in specificity from 80 to 66% (p Ͻ 0.0001). Negative predictive value rose significantly from 67 to 76% (p ϭ 0.008).
The three pretest probability groups (low to high) revealed the following trends: (1) no significant change in sensitivity or specificity, (2) a progressive increase in positive predictive value and a decrease in negative predictive value, and (3) a progressive increase in positive exercise ECG frequency. Concerning this last point, the larger unselected pretest probability subgroups had significantly lower frequencies of positive exercise tests, compared to the respec- tive angiography groups (low probability, 13% vs 36%; intermediate, 22% vs 53%; high, 36% vs 63%). Concerning incremental value (Table 3) , the exercise test did not add diagnostic value to the clinical data in the low and high pretest probability groups, but did add diagnostic value in the intermediateprobability group. Nevertheless, the probability of disease given a negative test result was very low (6%) in the low-probability group, and very high (72%) in the high-probability group. The intermediate pretest probability group demonstrated the greatest incremental value, but the probability of disease given a negative test was not very low (28%).
Discussion
The recommendations for exercise testing within pretest probability groups presented by the ACC/ AHA consensus group were based principally on the added or incremental value. The ROC curve area data on Table 3 support these assignments. However, the predictive value data tell another story. If the intermediate-probability patient undergoes exercise testing, a negative test result on average carries a 28% chance of being falsely negative. While this probability of being wrong will vary depending on how high or low the intermediate probability is, the bottom line is that exercise ECG in this group carries a substantial false-negative rate. Therefore, while the incremental value is there, the false-negative rate would weaken its value as a stand-alone screening test for those with an intermediate pretest probability.
Indications for Exercise ECG
High-probability patients on average carry a Ն 70% chance of having coronary disease. Given the marginal incremental value and the poor negative predictive value, exercise ECG alone is unlikely to be useful in making diagnostic decisions in this group. Others have suggested that coronary angiography 9 or imaging 10 would be a suitable initial strategy in high pretest probability patients.
Based on our data in symptomatic low-probability patients, the absence of incremental value would support the ACC/AHA classification as originally conceived. Without giving a ringing endorsement, the class IIb indication allows physicians to use their discretion in choosing exercise testing in these patients. Our data do not allow us to determine how physicians chose exercise testing. However, our data do indicate that a large percentage of patients referred for exercise testing are in the low-probability group. In fact, the percentage of low-probability patients referred to our laboratory has increased over time: from 1981 to 1989 (low, 31%; intermediate, 58%; high, 11%), and from 1990 to 1998 (low, 42%; intermediate, 48%; high, 10%).
Given the absence of incremental value in lowprobability patients, is there any value in performing this test in this group? While there was not a statistically significant difference, the curve areas were different (71% vs 76%). Given that we only had 148 low-probability patients, it is possible that with two or three times that number, statistical significance may have been achieved. Be that as it may, as stated earlier, given the strong negative predictive value and the low frequency of positive exercise tests, a negative test result can be reassuring to both physicians and patients that the probability of coronary disease is very low. Unfortunately, this type of value is difficult to measure. Until the development of a test with significant incremental value that is as available and inexpensive as the exercise ECG, physicians will likely continue to use the exercise ECG as a means to screen low-probability patients. Likewise, the use of exercise imaging as an initial strategy seems like an expensive way to accomplish the same goal. Others concur with this conclusion. 10 The use of exercise testing in intermediate-probability patients had the greatest incremental value, but the overall negative predictive value was only 72%, ie, about 3 of every 10 intermediate-probability patients would be falsely negative. However, the intermediate-probability group is a heterogeneous group with probabilities ranging from 10 to 90%. Those patients at the lower end of this probability range will likely have a negative predictive value significantly Ͼ 72%. On the other hand, those in the middle and upper ranges will likely have negative predictive values either equal to or significantly Ͻ 72%. For example, using previously published probability equations, 5,7 maximum and minimum posttest probabilities can be estimated for differing levels of intermediate pretest probability (Table 4 
Sensitivity and Specificity
All diagnostic tests are plagued with a frequency of false-positives and negatives. False-positive tests frequently subject the patient to additional testing (echocardiographic or nuclear imaging or coronary angiography). However, while false-positives are bothersome, false-negatives are entirely unwelcome. The false-negative exercise ECG represents a missed opportunity to make a diagnosis, which could lead to a completely unanticipated cardiac event, including death. Therefore, given that the potential consequences of false-positives and negatives are different, the minimization of false-negatives should be given stronger emphasis than the minimization of false-positives.
Many clinicians view sensitivity (probability of a positive test given the presence of disease) and specificity (probability of a negative test given the absence of disease) as the ultimate statement of the accuracy of a test. While sensitivity and specificity are stable with respect to disease prevalence, they are affected by a number of other influences, 12 including posttest referral bias (the preferential referral of patients with positive exercise ECG results to undergo coronary angiography). Philbrick et al 13 have pointed out that, at the time of their report, referral bias affected all of the exercise ECG literature such that it confounded the ability to know the accuracy of the exercise ECG in the unselected population that presents itself to the average clinician. Gianrossi et al 14 subsequently performed a meta-analysis of the exercise ECG literature to provide "consensus" values of sensitivity and specificity. Their values of 67% and 72%, respectively, have been widely quoted since that time. Unfortunately, rather than remove or adjust for referral bias, Gianrossi et al 14 simply averaged it into their analysis. Therefore, 67% and 72% represent the accuracy within populations with posttest referral bias. A recent meta-analysis in women accomplished much the same. 15 Froelicher et al 16 have revisited this issue by looking at the same meta-analysis data. They found a linear relationship between both sensitivity and specificity and the frequency of a positive exercise ECG (a marker for posttest referral bias). Those studies with a lower positive exercise ECG frequency had lower sensitivity and higher specificity when compared to those with a higher positive exercise ECG frequency. This would suggest that unbiased sensitivity would be lower and unbiased specificity would be higher than reported in the referral-biased metaanalysis. This phenomenon has been reported for exercise ECG, 17 exercise echocardiography, 18 and nuclear imaging. 19 Froelicher et al 20 have reported the results of a unique study, the Quantitative Exercise Testing and Angiography study. By design, they sought to minimize posttest referral bias by performing exercise ECGs and coronary angiography on all patients irrespective of indication or test results. They demonstrated that exercise ECG sensitivity and specificity in their predominantly male population were very different from the previous metaanalysis (sensitivity 45%, specificity 85%).
When assessing the accuracy of a diagnostic test such as the exercise ECG, both referral-biased and unbiased populations should be considered. Metaanalyses that average the results of studies with widely varying degrees of posttest referral bias are not appropriate and do not reflect the accuracy in the unselected population being seen in office and hospital settings. Given the difficulty in performing studies without referral bias, at the very least, only biased studies with the lowest positive test frequency should be included in the analysis.
Predictive Value
While sensitivity and specificity are reliable indicators of whether one test is better than another, (Table 2 ). Particularly noteworthy is the very high negative predictive value of the low pretest probability group. In a low-prevalence group, good specificity guarantees a large number of truenegatives and the low prevalence guarantees a small number of false-negatives. While the positive predictive value of the low-probability group is poor, the frequency of positive exercise ECGs is quite low (13%). Therefore, nearly 9 of 10 exercise ECGs in this group will be negative, with a 6% chance of being falsely negative.
This analysis works in women as well as in men. Despite lower specificity than men, the negative predictive value is very high and the frequency of a positive exercise ECG is only 15% (data not shown).
Considering the high-probability group, the high positive predictive value (92%) is obtained at the cost of a low negative predictive value. Given the relatively large frequency of negative tests generated by this group in unselected patients (64%, data not shown) and the low negative predictive value (28%), it is very unlikely that an initial exercise ECG diagnostic strategy would be cost-effective.
Considering the intermediate-probability group (recommended for exercise ECG by the ACC/AHA guidelines), the predictive values are fair at best. Nearly 3 of every 10 negative results would be falsely negative.
Limitations of Present Study
We limited our analysis to a consideration of ST-segment depression alone. Peak exercise heart rate, the Duke treadmill score, and ST/heart rate index have all been shown to have additional diagnostic [21] [22] [23] as well as prognostic 22, 24, 25 value over ST-segment depression alone. Future studies should consider these additional variables.
The ACC/AHA guidelines 1 recommended a modification of the Diamond-Forrester method for determining pretest probability. The method we used accomplishes the same objective, but incorporates more clinical data. 5 A recent report from our laboratory indicates that the two methods yield similar prevalences for the three pretest probability groups. 26 We would not expect the conclusions of this study to be different using the Diamond-Forrester method.
The present study, by its very design, was retrospective and observational without an evaluation of outcomes, costs, or the decisions regarding referral for exercise testing. Confirming the findings of this study with a prospective randomized trial of differing strategies with appropriate attention to pretest probability, diagnostic and prognostic outcomes, and costs would be a welcome addition to a literature that is already full of observational studies.
Conclusions and Clinical Implications
Our purpose was to evaluate the recently published ACC/AHA guidelines regarding patient appropriateness for diagnostic exercise ECG. The results of this study support the guidelines as appropriate. However, each of the three pretest probability groups requires qualifying statements concerning the usage of exercise testing. The guidelines suggest that physicians consider probability analysis in their interpretation of exercise tests. The following is offered for the clinician as an alternative to a strict computational probability analysis approach.
First, patients with a low pretest probability of coronary disease who are selected for exercise testing should undergo exercise ECG alone (assuming resting ECG and exercise status allow). In both men and women, negative test results are frequent and carry a very high negative predictive value. Positive test results are infrequent and are likely to be falsely positive. These can be evaluated further by exercise imaging studies.
Second, intermediate-probability patients should all undergo at least an initial exercise ECG. Selected individuals in this group with higher pretest probabilities (or a higher pretest score) should undergo combined exercise ECG and imaging as the initial strategy. This is due to the low negative predictive value of the exercise ECG in these patients.
Third, high pretest probability patients rightfully deserve a class III indication. This is due to the marginal incremental value, the poor negative predictive value, and the relatively high frequency of negative test results in this group. If the diagnosis needs to be clarified, then coronary angiography would be an appropriate initial strategy in these patients. The exercise ECG could be used to prognosticate or risk stratify these patients into low-or high-risk prognostic groups, ie, prognostically signif-icant disease that would warrant revascularization (class I under the prognostic indications; section III of the guidelines).
